Clinical Trial Update: Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled nitric oxide for severe respiratory failure in preterm infants; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Birth Complications
• Pulmonary Hypertension
• Respiratory Distress Syndrome

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: NICHD Neonatal Research Network | Conditions: Infant, Newborn, Infant, Low Birth Weight | Phase 3 | Status: TERMINATED